Eva Hellström‐Lindberg

7.3k total citations
29 papers, 1.9k citations indexed

About

Eva Hellström‐Lindberg is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Eva Hellström‐Lindberg has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 11 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Eva Hellström‐Lindberg's work include Acute Myeloid Leukemia Research (27 papers), Bone and Joint Diseases (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Eva Hellström‐Lindberg is often cited by papers focused on Acute Myeloid Leukemia Research (27 papers), Bone and Joint Diseases (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Eva Hellström‐Lindberg collaborates with scholars based in Sweden, Italy and United Kingdom. Eva Hellström‐Lindberg's co-authors include Martin Jädersten, Luca Malcovati, Mario Cazzola, Andrea Pellagatti, Jacqueline Boultwood, Matteo Giovanni Della Porta, James S. Wainscoat, Aristoteles Giagounidis, Sally Killick and Birger Christensson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Eva Hellström‐Lindberg

29 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Hellström‐Lindberg Sweden 20 1.5k 855 758 167 156 29 1.9k
Martin Jädersten Sweden 22 1.7k 1.1× 857 1.0× 795 1.0× 241 1.4× 205 1.3× 63 2.1k
Erica Travaglino Italy 20 2.0k 1.3× 488 0.6× 1.3k 1.7× 145 0.9× 107 0.7× 57 2.3k
Frédérik Damm Germany 23 1.7k 1.1× 1.2k 1.4× 780 1.0× 116 0.7× 492 3.2× 58 2.2k
Ingunn Dybedal Norway 19 1.5k 1.0× 429 0.5× 781 1.0× 384 2.3× 48 0.3× 39 1.9k
Kimberly Hayes United States 19 833 0.6× 428 0.5× 753 1.0× 172 1.0× 114 0.7× 38 1.5k
Anna Gallì Italy 17 800 0.5× 344 0.4× 593 0.8× 138 0.8× 123 0.8× 55 1.1k
Jane E. Churpek United States 18 621 0.4× 360 0.4× 282 0.4× 86 0.5× 241 1.5× 45 1.1k
Christian Flotho Germany 23 883 0.6× 974 1.1× 356 0.5× 179 1.1× 160 1.0× 62 1.6k
Zhaohui Gu United States 15 808 0.5× 855 1.0× 272 0.4× 92 0.6× 262 1.7× 36 1.4k

Countries citing papers authored by Eva Hellström‐Lindberg

Since Specialization
Citations

This map shows the geographic impact of Eva Hellström‐Lindberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellström‐Lindberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellström‐Lindberg more than expected).

Fields of papers citing papers by Eva Hellström‐Lindberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hellström‐Lindberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellström‐Lindberg. The network helps show where Eva Hellström‐Lindberg may publish in the future.

Co-authorship network of co-authors of Eva Hellström‐Lindberg

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hellström‐Lindberg. A scholar is included among the top collaborators of Eva Hellström‐Lindberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hellström‐Lindberg. Eva Hellström‐Lindberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nilsson, Lars, Magnus Tobiasson, Martin Jädersten, et al.. (2025). Influence of Cytogenetics on the Outcome of Patients With High‐Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide. Genes Chromosomes and Cancer. 64(2). e70029–e70029. 1 indexed citations
2.
Shiozawa, Yusuke, Luca Malcovati, Anna Gallì, et al.. (2018). Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Nature Communications. 9(1). 3649–3649. 111 indexed citations
3.
Yip, Bon Ham, Violetta Steeples, Emmanouela Repapi, et al.. (2017). The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes. Journal of Clinical Investigation. 127(6). 2206–2221. 70 indexed citations
4.
Gerstung, Moritz, Andrea Pellagatti, Luca Malcovati, et al.. (2015). Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nature Communications. 6(1). 5901–5901. 148 indexed citations
5.
Pellagatti, Andrea, Axel Benner, Ken Mills, et al.. (2012). Identification of Gene Expression Based Prognostic Markers in the Hematopoietic Stem Cells of Patients with Myelodysplastic Syndromes. Blood. 120(21). 3857–3857. 1 indexed citations
6.
Silverman, Lewis R., Pierre Fenaux, Ghulam J. Mufti, et al.. (2011). Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes. Cancer. 117(12). 2697–2702. 138 indexed citations
7.
Pellagatti, Andrea, Mario Cazzola, Aristoteles Giagounidis, et al.. (2010). Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia. 24(4). 756–764. 188 indexed citations
8.
9.
Malcovati, Luca, Angela Brisci, Anna Gallì, et al.. (2010). Mutation Analysis of TET2 Reveals the Clonal Nature of Refractory Anemia with Ring Sideroblasts. Blood. 116(21). 1862–1862. 1 indexed citations
10.
Löfström, Björn, Carin Backlin, Christer Sundström, et al.. (2009). Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers. Lara D. Veeken. 48(10). 1222–1226. 30 indexed citations
11.
Jädersten, Martin, Leonie Saft, Andrea Pellagatti, et al.. (2009). Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression. Haematologica. 94(12). 1762–1766. 66 indexed citations
12.
Boultwood, Jacqueline, Andrea Pellagatti, Maryam Nikpour, et al.. (2008). The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts. PLoS ONE. 3(4). e1970–e1970. 87 indexed citations
13.
Pellagatti, Andrea, Eva Hellström‐Lindberg, Aristoteles Giagounidis, et al.. (2008). Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal‐ and translation‐related genes. British Journal of Haematology. 142(1). 57–64. 65 indexed citations
14.
Pellagatti, Andrea, Martin Jädersten, Ann‐Mari Forsblom, et al.. (2007). Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q− syndrome patients. Proceedings of the National Academy of Sciences. 104(27). 11406–11411. 170 indexed citations
15.
Pellagatti, Andrea, M. Cazzola, Aristoteles Giagounidis, et al.. (2007). C023 Expression profiling of CD34+ cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes. Leukemia Research. 31. S35–S35. 1 indexed citations
16.
Tehranchi, Ramin, Bengt Fadeel, Ann‐Mari Forsblom, et al.. (2003). Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. Blood. 101(3). 1080–1086. 97 indexed citations
17.
Tehranchi, Ramin, Bertrand Joseph, Birger Christensson, et al.. (2001). Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts. Leukemia. 15(5). 742–751. 29 indexed citations
18.
Hellström‐Lindberg, Eva, Robert S. Negrin, Richard S. Stein, et al.. (1997). Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. British Journal of Haematology. 99(2). 344–351. 216 indexed citations
19.
Hellström‐Lindberg, Eva, Karl‐Henrik Robèrt, Gösta Gahrton, et al.. (1994). Low-Dose Ara-C in Myelodysplastic Syndromes (MDS) and Acute Leukemia Following MDS: Proposal for a Predictive Model. Leukemia & lymphoma. 12(5-6). 343–351. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Jädersten Breakdown of academic impact, for papers by Erica Travaglino Breakdown of academic impact, for papers by Frédérik Damm Breakdown of academic impact, for papers by Ingunn Dybedal Breakdown of academic impact, for papers by Kimberly Hayes Breakdown of academic impact, for papers by Anna Gallì Breakdown of academic impact, for papers by Jane E. Churpek Breakdown of academic impact, for papers by Christian Flotho Breakdown of academic impact, for papers by Zhaohui Gu
Rankless by CCL
2026